RI-Based MindImmune Therapeutics Raises $12.4M in Series A Financing

Go Local Prov Business

Jun 14, 2022

MindImmune Therapeutics Inc., a Rhode Island-based drug discovery company says that it is "pioneering a new approach to treat Alzheimer's disease and other neuro-degenerative condi…